Summary of patient anatomical data and scan locations, along with noted clinical events
| ID . | Age . | Sex . | BMI . | Dg . | EF, % . | Indication for S-ICD . | Heating . |
|---|---|---|---|---|---|---|---|
| 01 | 64 | F | 20.5 | HCMP/VFs | 85 | Secondary prevention | None |
| 02 | 83 | M | 30.0 | Post-MI/SMVTs post-catheter ablation/ | 35 | Secondary prevention (post-transvenous ICD extraction) | None |
| 03 | 31 | M | 25.3 | ARVC/D/SMVTs | 68 | Secondary prevention | In-tolerable re-scanned |
| 04 | 58 | M | 23.6 | Post-MI/post-CABG | 30 | Primary prevention | None |
| 05 | 77 | M | 25.5 | Post-MI | 30 | Primary prevention | None |
| 06 | 63 | M | 27.0 | Post-MI | 30 | Primary prevention | None |
| 07 | 68 | M | 23.7 | Post-MI/VFs/VTs | 60 | Secondary prevention post-transvenous ICD extraction/SVC occlusion | Tolerable |
| 08 | 22 | M | 29.4 | Brugada sy/VFs | 68 | Secondary prevention | In-tolerable re-scanned |
| 09 | 59 | M | 27.1 | DCMP/VFs/post-mitral valve surgery/ | 60 | Secondary prev./post-transvenous ICD extraction | None |
| 10 | 41 | F | 24.6 | ARVC/D | 70 | Primary prevention | None |
| 11 | 23 | F | 21.5 | LQTS/VF | 60 | Secondary prevention | None |
| 12 | 66 | M | 36.9 | Post-MI/VF/post-CABG | 50 | Secondary prevention/post-repeat transvenous ICD extraction | Tolerable |
| 13 | 48 | M | 22.9 | DCMP(non-compaction)/VFs | 35 | Secondary prevention | None |
| 14 | 70 | M | 29 | Systolic dysfunction of LV | 35 | Primary prevention | None |
| 15 | 26 | M | 33 | Brugada sy | 65 | Primary prevention | None |
| ID . | Age . | Sex . | BMI . | Dg . | EF, % . | Indication for S-ICD . | Heating . |
|---|---|---|---|---|---|---|---|
| 01 | 64 | F | 20.5 | HCMP/VFs | 85 | Secondary prevention | None |
| 02 | 83 | M | 30.0 | Post-MI/SMVTs post-catheter ablation/ | 35 | Secondary prevention (post-transvenous ICD extraction) | None |
| 03 | 31 | M | 25.3 | ARVC/D/SMVTs | 68 | Secondary prevention | In-tolerable re-scanned |
| 04 | 58 | M | 23.6 | Post-MI/post-CABG | 30 | Primary prevention | None |
| 05 | 77 | M | 25.5 | Post-MI | 30 | Primary prevention | None |
| 06 | 63 | M | 27.0 | Post-MI | 30 | Primary prevention | None |
| 07 | 68 | M | 23.7 | Post-MI/VFs/VTs | 60 | Secondary prevention post-transvenous ICD extraction/SVC occlusion | Tolerable |
| 08 | 22 | M | 29.4 | Brugada sy/VFs | 68 | Secondary prevention | In-tolerable re-scanned |
| 09 | 59 | M | 27.1 | DCMP/VFs/post-mitral valve surgery/ | 60 | Secondary prev./post-transvenous ICD extraction | None |
| 10 | 41 | F | 24.6 | ARVC/D | 70 | Primary prevention | None |
| 11 | 23 | F | 21.5 | LQTS/VF | 60 | Secondary prevention | None |
| 12 | 66 | M | 36.9 | Post-MI/VF/post-CABG | 50 | Secondary prevention/post-repeat transvenous ICD extraction | Tolerable |
| 13 | 48 | M | 22.9 | DCMP(non-compaction)/VFs | 35 | Secondary prevention | None |
| 14 | 70 | M | 29 | Systolic dysfunction of LV | 35 | Primary prevention | None |
| 15 | 26 | M | 33 | Brugada sy | 65 | Primary prevention | None |
HCMP, hypertrophic cardiomyopathy ; SMVT, sustained monomorphic ventricular tachycardia; MI, myocardial infarction; ARVC, arrhythmogenic right ventricular cardiomyopathy; CABG, coronary artery by-pass graft; LQTS, long QT syndrom.
Summary of patient anatomical data and scan locations, along with noted clinical events
| ID . | Age . | Sex . | BMI . | Dg . | EF, % . | Indication for S-ICD . | Heating . |
|---|---|---|---|---|---|---|---|
| 01 | 64 | F | 20.5 | HCMP/VFs | 85 | Secondary prevention | None |
| 02 | 83 | M | 30.0 | Post-MI/SMVTs post-catheter ablation/ | 35 | Secondary prevention (post-transvenous ICD extraction) | None |
| 03 | 31 | M | 25.3 | ARVC/D/SMVTs | 68 | Secondary prevention | In-tolerable re-scanned |
| 04 | 58 | M | 23.6 | Post-MI/post-CABG | 30 | Primary prevention | None |
| 05 | 77 | M | 25.5 | Post-MI | 30 | Primary prevention | None |
| 06 | 63 | M | 27.0 | Post-MI | 30 | Primary prevention | None |
| 07 | 68 | M | 23.7 | Post-MI/VFs/VTs | 60 | Secondary prevention post-transvenous ICD extraction/SVC occlusion | Tolerable |
| 08 | 22 | M | 29.4 | Brugada sy/VFs | 68 | Secondary prevention | In-tolerable re-scanned |
| 09 | 59 | M | 27.1 | DCMP/VFs/post-mitral valve surgery/ | 60 | Secondary prev./post-transvenous ICD extraction | None |
| 10 | 41 | F | 24.6 | ARVC/D | 70 | Primary prevention | None |
| 11 | 23 | F | 21.5 | LQTS/VF | 60 | Secondary prevention | None |
| 12 | 66 | M | 36.9 | Post-MI/VF/post-CABG | 50 | Secondary prevention/post-repeat transvenous ICD extraction | Tolerable |
| 13 | 48 | M | 22.9 | DCMP(non-compaction)/VFs | 35 | Secondary prevention | None |
| 14 | 70 | M | 29 | Systolic dysfunction of LV | 35 | Primary prevention | None |
| 15 | 26 | M | 33 | Brugada sy | 65 | Primary prevention | None |
| ID . | Age . | Sex . | BMI . | Dg . | EF, % . | Indication for S-ICD . | Heating . |
|---|---|---|---|---|---|---|---|
| 01 | 64 | F | 20.5 | HCMP/VFs | 85 | Secondary prevention | None |
| 02 | 83 | M | 30.0 | Post-MI/SMVTs post-catheter ablation/ | 35 | Secondary prevention (post-transvenous ICD extraction) | None |
| 03 | 31 | M | 25.3 | ARVC/D/SMVTs | 68 | Secondary prevention | In-tolerable re-scanned |
| 04 | 58 | M | 23.6 | Post-MI/post-CABG | 30 | Primary prevention | None |
| 05 | 77 | M | 25.5 | Post-MI | 30 | Primary prevention | None |
| 06 | 63 | M | 27.0 | Post-MI | 30 | Primary prevention | None |
| 07 | 68 | M | 23.7 | Post-MI/VFs/VTs | 60 | Secondary prevention post-transvenous ICD extraction/SVC occlusion | Tolerable |
| 08 | 22 | M | 29.4 | Brugada sy/VFs | 68 | Secondary prevention | In-tolerable re-scanned |
| 09 | 59 | M | 27.1 | DCMP/VFs/post-mitral valve surgery/ | 60 | Secondary prev./post-transvenous ICD extraction | None |
| 10 | 41 | F | 24.6 | ARVC/D | 70 | Primary prevention | None |
| 11 | 23 | F | 21.5 | LQTS/VF | 60 | Secondary prevention | None |
| 12 | 66 | M | 36.9 | Post-MI/VF/post-CABG | 50 | Secondary prevention/post-repeat transvenous ICD extraction | Tolerable |
| 13 | 48 | M | 22.9 | DCMP(non-compaction)/VFs | 35 | Secondary prevention | None |
| 14 | 70 | M | 29 | Systolic dysfunction of LV | 35 | Primary prevention | None |
| 15 | 26 | M | 33 | Brugada sy | 65 | Primary prevention | None |
HCMP, hypertrophic cardiomyopathy ; SMVT, sustained monomorphic ventricular tachycardia; MI, myocardial infarction; ARVC, arrhythmogenic right ventricular cardiomyopathy; CABG, coronary artery by-pass graft; LQTS, long QT syndrom.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
